News

New research suggests that receiving multiple doses of a vaccine in the same limb leads to faster antibody development, an important strategy for providing immunity as quickly as possible during a pandemic or disease outbreak.

Tel Aviv University researchers used CRISPR to cut the SOX2 gene from head and neck cancer cells, eliminating 50% of tumors in mice. The study highlights CRISPR’s potential for cancer treatment.

Researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine using virus-like particles (VLPs).

Researchers at the University of Colorado Anschutz Medical Campus have successfully developed an iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the cells, particularly against hard-to-treat cancer cells.

A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according to a preclinical study led by Weill Cornell Medicine investigators.

A universal vascular graft made from stem cell-derived arterial endothelial cells could advance the field of vascular bypass surgery.

A discovery in cardiac regeneration offers ew hope for the treatment of ischemic heart failure. Published in npj Regenerative Medicine, the study reveals a novel approach to promoting cardiomyocyte proliferation.

Johns Hopkins scientists have developed an mRNA “booster” as a potential new way to treat rare genetic diseases marked by too low levels of specific cellular proteins.

Reprogrammed stem cells to replace dopamine cells in the brain may offer hope for Parkinson's treatment as a phase 1 trial to test the approach launches.

Researchers have discovered how antibodies help to protect against contagious bacterial infections caused by Strep A, including strep throat. The findings are contributing to efforts to accelerate the development of a Strep A vaccine.